Amide Pharmaceutical

Amide Pharmaceutical is a global biotechnology company at the forefront of treatments for rare and orphan diseases. Amide Pharmaceutical has a unique set of platform technologies and drugs developed for individuals suffering from rare and devastating diseases, including lysosomal storage disorders, Fabry disease, Pompe disease, as well as hereditary connective tissue skin disorders, Epidermolysis Bullosa (EB).